Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in CKD
Clinical Journal of the American Society of Nephrology · 2026
DOI: 10.2215/cjn.0000001092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, 2026. Verfasst von Minsang Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Renal Insufficiency, Renal Insufficiency, Chronic. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Health (KR), Ministry of Health and Welfare.
Abstract (Originalsprache)
Key Points Clonal hematopoiesis of indeterminate potential was more prevalent in patients with CKD than the general population. Clonal hematopoiesis of indeterminate potential was associated with a higher risk of kidney failure in patients with CKD across both the Korean and European ancestry populations. Variant allele fraction of clonal hematopoiesis of indeterminate potential‑associated mutations was higher in patients with CKD than those without CKD.
Background
Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition associated with inflammation. Although CKD shares these pathophysiological features, the prognostic role of CHIP on CKD progression remains unclear, particularly in underrepresented East Asian populations.
Methods
Deep targeted sequencing of CHIP-driving mutations was used to identify the presence of CHIP, defined as variant allele fraction (VAF) ≥2.0%. CHIP prevalence was compared between 175 Korean participants with CKD in the Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) cohort and 700 matched general population controls in the Gene-Environmental Interaction and Phenotype (GENIE) cohort. The association between CHIP and kidney failure (KF) risk was evaluated using multivariable Cox regression analysis both in the KNOW-CKD cohort and 232 matched UK Biobank participants with CKD. Furthermore, VAF was compared between CHIP-positive participants in the KNOW-CKD and GENIE cohorts.
Results
The prevalence of CHIP was significantly higher in the KNOW-CKD cohort than in the GENIE cohort (17% versus 11%; P = 0.04). Over a median follow-up of 10.0 years, 66 participants (38%) developed KF in the KNOW-CKD cohort. After multivariable adjustment, CHIP was associated with higher risk of KF (adjusted hazard ratio, 1.90; 95% confidence interval, 1.03 to 3.51). Furthermore, in the UK Biobank, KF occurred in 43 participants (20%) over a median follow-up of 12.9 years and the association of CHIP with higher risk of KF was consistently observed (adjusted hazard ratio, 2.16; 95% confidence interval, 1.15 to 4.03). Furthermore, among CHIP-positive participants, the median VAF of CHIP-associated mutations was significantly higher in participants within the KNOW-CKD cohort compared with healthy controls in the GENIE cohort (7.3% versus 4.4%; P = 0.02).
Conclusions
CHIP is more prevalent in patients with CKD and serves as an independent risk factor of KF. This association is consistently observed across both an underrepresented East Asian cohort and a European cohort, establishing CHIP as a globally relevant risk factor of CKD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
- NOBO Medicine, Inc., Seoul, Republic of Korea.
- Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Internal Medicine, College of Medicine, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
ORCID-Profile: Sanyeowool An, Hyunjin Ryu, Choonghyun Sun, Hong Yul An, Gangpyo Ryu, Jayoun Kim, Yaeni Kim, Soo Wan Kim, Yeong Hoon Kim, Siddhartha Jaiswal, Kook-Hwan Oh
Förderung
- National Institute of Health (KR)
- Ministry of Health and Welfare
Zitieren
APA
Kim, M., An, S., Ryu, H., Sun, C., An, H. Y., Ryu, G., Kim, J., Kim, Y., Kim, S. W., Kim, Y. H., Jaiswal, S., Koh, Y., & Oh, K. H. (2026). Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in CKD. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001092
Vancouver
Kim M, An S, Ryu H, Sun C, An HY, Ryu G, et al. Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in CKD. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001092
BibTeX
@article{Kim2026,
author = {Kim, Minsang and An, Sanyeowool and Ryu, Hyunjin and Sun, Choonghyun and An, Hong Yul and Ryu, Gangpyo and Kim, Jayoun and Kim, Yaeni and Kim, Soo Wan and Kim, Yeong Hoon and Jaiswal, Siddhartha and Koh, Youngil and Oh, Kook-Hwan},
title = {Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in CKD},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
doi = {10.2215/cjn.0000001092}
}
EUVIMED